Lujo mammarenavirus
| Amiodarone | LUJV | Non-competitive β-adrenergic inhibitor | Preclinical | — | Human (multiple) | |
| Apilimod | LUJV | PIKfyve kinase inhibitor | Preclinical | — | Human PTK | |
| AVN-944 | LUJV | IMPDH inhibitor | Preclinical | — | Human IMPDH | |
| Benztropine | LUJV | Selective inhibition of dopamine transporters but it also presents affinity for histamine and muscarine receptors | Preclinical | — | Human CHRM1 | |
| Brequinar | LUJV | Dihydroorotate dehydrogenase (DHODH) inhibitor | Preclinical | — | Human DHODH | |
| Favipiravir | LUJV | Viral RNA polymerase inhibitor | Approved (other) | Japan | Viral RNA pol | |
| Mycophenolic acid | LUJV | Inosine monophosphate dehydrogenase inhibitor | Preclinical | — | Human IMPDH | |
| Niclosamide | LUJV | Unknown | Preclinical | — | Human (multiple) | |
| Obatoclax | LUJV | Bcl-2 family inhibitor | Preclinical | — | Human MCL1 | |
| Raloxifene | LUJV | Selective estrogen receptor modulator | Preclinical | — | Human (multiple) | |
| Tamoxifen | LUJV | Estrogen receptor antagonist | Preclinical | — | Human (multiple) | |
| Toremifene | LUJV | Estrogen receptor alpha modulator | Preclinical | — | Human Human ER |